(Q42219174)

18 October 2017

title

Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment (English)

1 reference

18 October 2017

0 references

Lawrence M Condon

1

1 reference

18 October 2017

Laurel E Cederberg

2

1 reference

18 October 2017

Mark D Rabinovitch

3

1 reference

18 October 2017

Rhoda V Liebo

4

1 reference

18 October 2017

Janice C Go

5

1 reference

18 October 2017

Amanda S Delaney

6

1 reference

18 October 2017

David O Schmeling

7

1 reference

18 October 2017

William Thomas

8

1 reference

18 October 2017

Henry H Balfour

9

1 reference

18 October 2017

language of work or name

English

0 references

publication date

11 May 2014

1 reference

Clinical Infectious Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

59

1 reference

18 October 2017

issue

4

1 reference

18 October 2017

page(s)

501-508

1 reference

Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Prevalence of Antibodies to Epstein-Barr Virus(EBV) in Childhood and Adolescence in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Seroepidemiologic Study of Epstein-Barr Virus Infections in a Rural Community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Primary Epstein-Barr virus infection in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Progress, prospects, and problems in Epstein-Barr virus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU342

21 January 2018

Identifiers

DOI

10.1093/CID/CIU342

1 reference

18 October 2017

1 reference